Pharmacology, Toxicology and Pharmaceutical Science
Antibody Drug Conjugate
100%
DNA
100%
Proteochondroitin Sulfate
85%
Rufloxacin
85%
Melanoma
85%
Cytotoxicity
42%
Acetone
42%
Carbon 11
42%
Neoplasm
42%
Toxicity
17%
Vadastuximab Talirine
14%
Talirine
14%
Pyrrolidine Derivative
14%
Imine
14%
Element
14%
Glycoprotein
8%
Alkylating Agent
8%
Antibody
8%
Tolerability
8%
Immunotherapy
8%
Tumor Regression
8%
Apoptosis
8%
Absence
8%
Tumor Antigen
8%
Dimer
8%
Monoclonal Antibody
8%
Medicine and Dentistry
Antibody-Drug Conjugate
85%
Proteochondroitin Sulfate
85%
Nodular Melanoma
85%
Rufloxacin
85%
In Vitro
17%
Xenograft
17%
Neoplasm
17%
Tumor Cell
17%
Toxicity
17%
Tumor Regression
8%
Therapeutic Procedure
8%
Melanoma Cell
8%
Alkylating Antineoplastic Agent
8%
Programmed Cell Death
8%
Combination Therapy
8%
Antibody
8%
Injection
8%
Colony Formation
8%
DNA Cross Linking
8%
Monoclonal Antibody
8%
Antineoplastic Activity
8%
Absence
8%
Tumor Antigen
8%
Neural Crest
8%
Growth
8%
Glycoprotein
8%
Signal Transduction
8%
Cell Growth
8%
Dimer
8%
Immunotherapy
8%
Immunology and Microbiology
Chondroitin Sulfate Proteoglycan
85%
Antibody Drug Conjugate
85%
Dose
17%
Xenograft
17%
Tumor Cell
17%
Melanoma Cell
8%
Cell Culture
8%
Monoclonal Antibodies
8%
Monospecific Antibody
8%
Neural Crest
8%
Cell Growth
8%
Tumor-Associated Antigen
8%
DNA Cross Linking
8%
Immunotherapy
8%
Growth
8%
Signal Transduction
8%
Apoptosis
8%
Colony Formation
8%
Antineoplastic Activity
8%